Biotechnology in Japan
Summary
Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.Synopsis
Essential resource for top-line data and analysis covering the Japan biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.Key Highlights
- The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
- The Japanese biotechnology industry had total revenues of $35.8bn in 2016, representing a compound annual growth rate (CAGR) of 3% between 2012 and 2016.
- The environment and industrial processing segment was the industry's most lucrative in 2016, with total revenues of $13.9bn, equivalent to 38.9% of the industry's overall value.
- With the increasing targets for reducing Japan’s carbon footprint, there is a growing requirement for the environment and industrial processing segment.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Japan
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Japan
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Japan biotechnology market with five year forecasts
- What was the size of the Japan biotechnology market by value in 2016?
- What will be the size of the Japan biotechnology market in 2021?
- What factors are affecting the strength of competition in the Japan biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Japan's biotechnology market?
- Executive Summary
- Market value
- Market value forecast
- Category segmentation
- Geography segmentation
- Market rivalry
- Market Overview
- Market definition
- Market analysis
- Market Data
- Market value
- Market Segmentation
- Category segmentation
- Geography segmentation
- Market Outlook
- Market value forecast
- Five Forces Analysis
- Summary
- Buyer power
- Supplier power
- New entrants
- Threat of substitutes
- Degree of rivalry
- Leading Companies
- Astellas Pharma Inc.
- Daiichi Sankyo Co., Ltd.
- Mitsubishi Tanabe Pharma Corporation
- Takeda Pharmaceutical Company Limited
- Macroeconomic Indicators
- Country data
- Methodology
- Industry associations
- Related MarketLine research
- Appendix
- About MarketLine
- List of Tables
- Table 1: Japan biotechnology industry value: $ billion, 2012-16
- Table 2: Japan biotechnology industry category segmentation: $ billion, 2016
- Table 3: Japan biotechnology industry geography segmentation: $ billion, 2016
- Table 4: Japan biotechnology industry value forecast: $ billion, 2016-21
- Table 5: Astellas Pharma Inc.: key facts
- Table 6: Astellas Pharma Inc.: key financials ($)
- Table 7: Astellas Pharma Inc.: key financials (¥)
- Table 8: Astellas Pharma Inc.: key financial ratios
- Table 9: Daiichi Sankyo Co., Ltd.: key facts
- Table 10: Daiichi Sankyo Co., Ltd.: key financials ($)
- Table 11: Daiichi Sankyo Co., Ltd.: key financials (¥)
- Table 12: Daiichi Sankyo Co., Ltd.: key financial ratios
- Table 13: Mitsubishi Tanabe Pharma Corporation: key facts
- Table 14: Mitsubishi Tanabe Pharma Corporation: key financials ($)
- Table 15: Mitsubishi Tanabe Pharma Corporation: key financials (¥)
- Table 16: Mitsubishi Tanabe Pharma Corporation: key financial ratios
- Table 17: Takeda Pharmaceutical Company Limited: key facts
- Table 18: Takeda Pharmaceutical Company Limited: key financials ($)
- Table 19: Takeda Pharmaceutical Company Limited: key financials (¥)
- Table 20: Takeda Pharmaceutical Company Limited: key financial ratios
- Table 21: Japan size of population (million), 2012-16
- Table 22: Japan gdp (constant 2005 prices, $ billion), 2012-16
- Table 23: Japan gdp (current prices, $ billion), 2012-16
- Table 24: Japan inflation, 2012-16
- Table 25: Japan consumer price index (absolute), 2012-16
- Table 26: Japan exchange rate, 2012-16
- List of Figures
- Figure 1: Japan biotechnology industry value: $ billion, 2012-16
- Figure 2: Japan biotechnology industry category segmentation: % share, by value, 2016
- Figure 3: Japan biotechnology industry geography segmentation: % share, by value, 2016
- Figure 4: Japan biotechnology industry value forecast: $ billion, 2016-21
- Figure 5: Forces driving competition in the biotechnology industry in Japan, 2016
- Figure 6: Drivers of buyer power in the biotechnology industry in Japan, 2016
- Figure 7: Drivers of supplier power in the biotechnology industry in Japan, 2016
- Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Japan, 2016
- Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Japan, 2016
- Figure 10: Drivers of degree of rivalry in the biotechnology industry in Japan, 2016
- Figure 11: Astellas Pharma Inc.: revenues & profitability
- Figure 12: Astellas Pharma Inc.: assets & liabilities
- Figure 13: Daiichi Sankyo Co., Ltd.: revenues & profitability
- Figure 14: Daiichi Sankyo Co., Ltd.: assets & liabilities
- Figure 15: Mitsubishi Tanabe Pharma Corporation: revenues & profitability
- Figure 16: Mitsubishi Tanabe Pharma Corporation: assets & liabilities
- Figure 17: Takeda Pharmaceutical Company Limited: revenues & profitability
- Figure 18: Takeda Pharmaceutical Company Limited: assets & liabilities
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook